Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)
Beijing Tongren Hospital
Beijing Tongren Hospital
University of Washington
City of Hope Medical Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Phoenix Children's Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Therapeutic Advances in Childhood Leukemia Consortium
University Hospital Schleswig-Holstein
Memorial Sloan Kettering Cancer Center
Aarhus University Hospital
Goethe University
Goethe University
Goethe University
Goethe University
St. Jude Children's Research Hospital
Gruppo Italiano Malattie EMatologiche dell'Adulto
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Gruppo Italiano Malattie EMatologiche dell'Adulto
Therapeutic Advances in Childhood Leukemia Consortium
UNICANCER
National Cancer Centre, Singapore
Samsung Medical Center
St. Jude Children's Research Hospital
Aristotle University Of Thessaloniki
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Therapeutic Advances in Childhood Leukemia Consortium
Gruppo Italiano Malattie EMatologiche dell'Adulto
University of Washington
The University of Hong Kong
Asan Medical Center
M.D. Anderson Cancer Center
The University of Hong Kong
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National University Hospital, Singapore
Alliance for Clinical Trials in Oncology
Sun Yat-sen University
PETHEMA Foundation
University Hospital, Lille
PETHEMA Foundation
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey